Researchers at Georgia State University have designed a protein that can effectively target a cell surface receptor linked to a number of diseases, including cancer. The researchers believe this synthetic protein, which they named ProAgio, has the potential to be a therapeutic treatment for various illnesses. Their work was recently published in Nature Communications. The
Type 1 diabetes (T1D) is an autoimmune disease where an individual’s immune cells destroy the beta cells of the pancreas. Beta cells are responsible for the production and secretion of insulin, a hormone that allows the body to use or store glucose from foods. People with T1D suffer from high blood glucose that can result
Here at Kerafast, we recently added the first monobody products to our catalog, prompting us to ask the question: what exactly is a monobody? Monobodies, as it turns out, are actually synthetic binding proteins. Based on a molecular scaffold composed of a fibronection type III domain (FN3), they are an alternative to traditional antibodies, belonging
Malaria parasites hijack a part of the human immune response called the complement system to invade red blood cells, according to new study published in EBioMedicine. This finding could help in the design, development and testing of more effective anti-malaria vaccines. The complement system The complement system, part of the innate immune system, consists of
A recent study published in the Nature-affiliated journal Scientific Reports describes the use of bacteriophage, or phage, to reverse resistance of the bacteria Pseudomonas aueroginosa to antibiotics. Phage are viruses that attack bacteria and this particular bacteriophage, OMKO1 (family Myoviridae), was found in a pond in East Lyme, Connecticut, not far from lead author Dr.
As a thank you to our customers, we’re holding a raffle this month to give away a pizza party to one lucky lab! Anyone who places an order in June will automatically be entered into the raffle. At the beginning of July, we will select and contact the winning laboratory. We will then work with